Figure 3. The Multi-marker Strategy.
A multi-marker strategy is likely to be needed in order to provide the cardiologist with a tool of adequate specificity and clinical utility. Markers to be included in a risk stratification model for SCD are likely to reflect different pathophysiological manifestations as illustrated above by the circles. Blue arrows indicate possible input from plasma biomarkers and red arrows other kinds of risk markers.